246 related articles for article (PubMed ID: 34753292)
1. Association of Diabetes With Atrial Fibrillation Phenotype and Cardiac and Neurological Comorbidities: Insights From the Swiss-AF Study.
Bano A; Rodondi N; Beer JH; Moschovitis G; Kobza R; Aeschbacher S; Baretella O; Muka T; Stettler C; Franco OH; Conte G; Sticherling C; Zuern CS; Conen D; Kühne M; Osswald S; Roten L; Reichlin T;
J Am Heart Assoc; 2021 Nov; 10(22):e021800. PubMed ID: 34753292
[TBL] [Abstract][Full Text] [Related]
2. Association of chocolate consumption with neurological and cardiovascular outcomes in atrial fibrillation: data from two Swiss atrial fibrillation cohort studies (Swiss-AF and BEAT-AF).
Stauber A; Müller A; Rommers N; Aeschbacher S; Rodondi N; Bonati LH; Beer JH; Jeger RV; Kurz DJ; Liedtke C; Ammann P; Di Valentino M; Chocano P; Kobza R; Kühne M; Conen D; Osswald S; Bernheim AM
Swiss Med Wkly; 2023 Aug; 153():40109. PubMed ID: 37609948
[TBL] [Abstract][Full Text] [Related]
3. Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.
Zelniker TA; Bonaca MP; Furtado RHM; Mosenzon O; Kuder JF; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Budaj A; Kiss RG; Padilla F; Gause-Nilsson I; Langkilde AM; Raz I; Sabatine MS; Wiviott SD
Circulation; 2020 Apr; 141(15):1227-1234. PubMed ID: 31983236
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
Bahit MC; Sacco RL; Easton JD; Meyerhoff J; Cronin L; Kleine E; Grauer C; Brueckmann M; Diener HC; Lopes RD; Brainin M; Lyrer P; Wachter R; Segura T; Granger CB;
Circulation; 2021 Nov; 144(22):1738-1746. PubMed ID: 34649459
[TBL] [Abstract][Full Text] [Related]
5. Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.
Echouffo-Tcheugui JB; Shrader P; Thomas L; Gersh BJ; Kowey PR; Mahaffey KW; Singer DE; Hylek EM; Go AS; Peterson ED; Piccini JP; Fonarow GC
J Am Coll Cardiol; 2017 Sep; 70(11):1325-1335. PubMed ID: 28882229
[TBL] [Abstract][Full Text] [Related]
6. Heart Rate Variability Triangular Index as a Predictor of Cardiovascular Mortality in Patients With Atrial Fibrillation.
Hämmerle P; Eick C; Blum S; Schlageter V; Bauer A; Rizas KD; Eken C; Coslovsky M; Aeschbacher S; Krisai P; Meyre P; Vesin JM; Rodondi N; Moutzouri E; Beer J; Moschovitis G; Kobza R; Di Valentino M; Corino VDA; Laureanti R; Mainardi L; Bonati LH; Sticherling C; Conen D; Osswald S; Kühne M; Zuern CS;
J Am Heart Assoc; 2020 Aug; 9(15):e016075. PubMed ID: 32750290
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation.
Witassek F; Springer A; Adam L; Aeschbacher S; Beer JH; Blum S; Bonati LH; Conen D; Kobza R; Kühne M; Moschovitis G; Osswald S; Rodondi N; Sticherling C; Szucs T; Schwenkglenks M;
PLoS One; 2019; 14(12):e0226730. PubMed ID: 31869399
[TBL] [Abstract][Full Text] [Related]
8. Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study.
Gumprecht J; Lip GYH; Sokal A; Średniawa B; Mitręga K; Stokwiszewski J; Wierucki Ł; Rajca A; Rutkowski M; Zdrojewski T; Grodzicki T; Kaźmierczak J; Opolski G; Kalarus Z
Cardiovasc Diabetol; 2021 Jun; 20(1):128. PubMed ID: 34167520
[TBL] [Abstract][Full Text] [Related]
9. Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities.
Chao TF; Lip GYH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
Eur Heart J; 2019 May; 40(19):1504-1514. PubMed ID: 30605505
[TBL] [Abstract][Full Text] [Related]
10. Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation.
Loring Z; Shrader P; Allen LA; Blanco R; Chan PS; Ezekowitz MD; Fonarow GC; Freeman JV; Gersh BJ; Mahaffey KW; Naccarelli GV; Pieper K; Reiffel JA; Singer DE; Steinberg BA; Thomas LE; Peterson ED; Piccini JP
Am Heart J; 2020 Jan; 219():21-30. PubMed ID: 31710841
[TBL] [Abstract][Full Text] [Related]
11. Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry.
Piccini JP; Simon DN; Steinberg BA; Thomas L; Allen LA; Fonarow GC; Gersh B; Hylek E; Kowey PR; Reiffel JA; Naccarelli GV; Chan PS; Spertus JA; Peterson ED;
JAMA Cardiol; 2016 Jun; 1(3):282-91. PubMed ID: 27438106
[TBL] [Abstract][Full Text] [Related]
12. Family History of Atrial Fibrillation and Risk of Cardiovascular Events: A Multicenter Prospective Cohort Study.
Pastori D; Menichelli D; Lip GYH; Sciacqua A; Violi F; Pignatelli P;
Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008477. PubMed ID: 32718257
[TBL] [Abstract][Full Text] [Related]
13. Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial.
Parcha V; Patel N; Kalra R; Kim J; Gutiérrez OM; Arora G; Arora P
Hypertension; 2020 Jun; 75(6):1483-1490. PubMed ID: 32362231
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
Vermond RA; Geelhoed B; Verweij N; Tieleman RG; Van der Harst P; Hillege HL; Van Gilst WH; Van Gelder IC; Rienstra M
J Am Coll Cardiol; 2015 Sep; 66(9):1000-7. PubMed ID: 26314526
[TBL] [Abstract][Full Text] [Related]
15. Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial.
Eisen A; Ruff CT; Braunwald E; Nordio F; Corbalán R; Dalby A; Dorobantu M; Mercuri M; Lanz H; Rutman H; Wiviott SD; Antman EM; Giugliano RP
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27402235
[TBL] [Abstract][Full Text] [Related]
16. Cognitive impairment, age, quality of life, and treatment strategy for atrial fibrillation in older adults: The SAGE-AF study.
Karnik AA; Saczynski JS; Chung JJ; Gurwitz JH; Bamgbade BA; Paul TJ; Lessard DM; McManus DD; Helm RH
J Am Geriatr Soc; 2022 Oct; 70(10):2818-2826. PubMed ID: 35735210
[TBL] [Abstract][Full Text] [Related]
17. Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery: A Randomized Clinical Trial.
Ha ACT; Verma S; Mazer CD; Quan A; Yanagawa B; Latter DA; Yau TM; Jacques F; Brown CD; Singal RK; Yamashita MH; Saha T; Teoh KH; Lam BK; Deyell MW; Wilson M; Hibino M; Cheung CC; Kosmopoulos A; Garg V; Brodutch S; Teoh H; Zuo F; Thorpe KE; Jüni P; Bhatt DL; Verma A;
JAMA Netw Open; 2021 Aug; 4(8):e2121867. PubMed ID: 34448866
[TBL] [Abstract][Full Text] [Related]
18. Impact of Atrial Fibrillation During ST-Segment-Elevation Myocardial Infarction on Infarct Characteristics and Prognosis.
Reinstadler SJ; Stiermaier T; Eitel C; Fuernau G; Saad M; Pöss J; de Waha S; Mende M; Desch S; Metzler B; Thiele H; Eitel I
Circ Cardiovasc Imaging; 2018 Feb; 11(2):e006955. PubMed ID: 29391346
[TBL] [Abstract][Full Text] [Related]
19. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
20. Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
Krisai P; Blum S; Aeschbacher S; Beer JH; Moschovitis G; Witassek F; Kobza R; Rodondi N; Moutzouri E; Mahmood A; Healey JS; Zuern CS; Kühne M; Osswald S; Conen D;
Heart; 2020 Dec; 106(23):1847-1852. PubMed ID: 32234819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
